Patent · US Expired

Integrin antagonists

US6245809A · kind A · utility

5Cited by
3References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 8, 1999
Grant dateJun 12, 2001
Priority date
Expiry dateJun 8, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel compounds, their salts and compositions related thereto having activity against mammalian integrins are disclosed. The compounds are useful in vitro or in vivo for preventing or treating thrombotic or restenotic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.